Diana Perkins

From Wikipedia, the free encyclopedia

Diana Perkins is an American professor at the University of North Carolina's (UNC) School of Medicine where she teaches psychiatry. She is a fellow of Consultation/Liaison Psychiatry and the Medical Director of Outreach and Support Intervention Services at UNC Hospitals and the UNC–Chapel Hill School of Medicine.[1] Perkins’ primary research interests include early identification and treatment of schizophrenia, emphasizing treatment of the prodromal period and early intervention of the first episode of schizophrenia. She is noted for publishing a study that demonstrated that using a polygenic risk score (PRS) based on data from genome-wide association studies improved the psychosis risk prediction in persons meeting clinical high-risk criteria.[2]

Education[]

Perkins' undergraduate work was completed at the University of Maryland in Psychology and Biochemistry; she also received her Doctor of Medicine there. She completed a graduate degree in Epidemiology from UNC.[3]

References[]

  1. ^ "Diana O. Perkins, MD | Global Medical Education". www.gmeded.com. Retrieved 25 March 2021.
  2. ^ Perkins, Diana O.; Olde Loohuis, Loes; Barbee, Jenna; Ford, John; Jeffries, Clark D.; Addington, Jean; Bearden, Carrie E.; Cadenhead, Kristin S.; Cannon, Tyrone D.; Cornblatt, Barbara A.; Mathalon, Daniel H.; McGlashan, Thomas H.; Seidman, Larry J.; Tsuang, Ming; Walker, Elaine F.; Woods, Scott W. (12 November 2019). "Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk". American Journal of Psychiatry. pp. 155–163. doi:10.1176/appi.ajp.2019.18060721.
  3. ^ "Diana Perkins". Department of Psychiatry. Retrieved 25 March 2021.

External links[]


Retrieved from ""